The administration of VTE prophylaxis appears to be suboptimal in patients with cirrhosis – possibly due to confusion about the relative risks of thrombotic events and bleeding. The retrospective study of 108 patients with cirrhosis at the University Hospital Geelong found only 56.5% received enoxaparin for VTE prophylaxis according to hospital guidelines. Yet in a ...
Study shows need for more education on VTE prophylaxis in cirrhosis
By Mardi Chapman
9 Mar 2018